Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
4
×
clinical trials
life sciences
boston blog main
boston top stories
national blog main
agios pharmaceuticals
alexion pharmaceuticals
alnylam pharmaceutials
arrowhead pharmaceuticals
artificial intelligence
biologic drugs
boehringer ingelheim
boston
boston xcon
boulder/denver xcon
cancer
cancer drugs
david e. shaw
deals
detroit xcon
dicerna pharmaceuticals
digital health
drug development
drug discovery
eli lilly
enasidenib
fda
genome sequencing
health
healthtech
hepatitis b
indiana blog main
indiana top stories
indiana xcon
innovation
investing
ipo
ivosidenib
johnson & johnson
What
development
4
×
medicines
4
×
clinical
drug
today
years
abandoning
ago
algorithms
baggage
batch
biologic
biotech
bottleneck
bottlenecks
called
combinator’s
companies
company’s
cost
course
cuts
deal
developing
dicerna
discover
dollars
dramatically
drugs
experimental
fix
fixing
free
genomic
gets
growing
handiwork
helped
interference
internal
Language
unset
Current search:
medicines
×
development
×
biotech
×
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
